ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Astrocytic Ketogenesis Protects Central Nervous System Injury via CPT1A Stabilization and Epigenetic Regulation.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Following central nervous system (CNS) injury, reactive astrocytes proliferate and encapsulate the lesion to facilitate repair. However, the specific metabolic characteristics remain unknown. Here, through integrated single-cell and spatial transcriptomics, we uncovered a subset of astrocytes that undergo enhanced lipid and ketone metabolic reprogramming following spinal cord injury (SCI). The ketone body β-hydroxybutyrate (β-OHB) inhibited autophagic degradation of carnitine-palmitoyltransferase-1A (CPT1A) via P300-mediated lysine β-hydroxybutyrylation (Kbhb). Astrocyte-specific deletion of Cpt1a led to impaired wound healing, reduced axonal sparing and worsened locomotor recovery after SCI, effects rescued by exogenous β-OHB. Mechanistically, ketogenesis promotes wound repair and lipid metabolic reprogramming, forming a positive feedback loop via H3K9bhb-dependent epigenetic remodeling in astrocytes after SCI. Furthermore, ketogenic diet (KD) promoted tissue repair across multiple CNS injury models. Clinically, elevated β-OHB levels were associated with better tissue preservation and functional recovery in SCI patients. Collectively, our findings underscore the critical role of astrocytic lipid metabolic and epigenetic reprogramming after CNS injury and identify KD as a promising therapeutic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.